Back to today’s briefing

Story perspectives

Wildfires Challenge Carbon Absorption Amid Breakthrough Drug Approval

7/29/2025

28 4

Summary

Story summary

Forests are struggling to absorb carbon as wildfires rage on, while the FDA has greenlit lenacapavir, a groundbreaking HIV prevention drug boasting nearly 100% effectiveness. In a bold move, Washington is suing the federal government over lost migrant shelter funds. Meanwhile, companies are tapping into AI for personalized pricing, sparking privacy worries, and psilocybin emerges as a promising agent for extending mice lifespans.

1 of 1

Story summary

Forests are struggling to absorb carbon as wildfires rage on, while the FDA has greenlit lenacapavir, a groundbreaking HIV prevention drug boasting nearly 100% effectiveness. In a bold move, Washington is suing the federal government over lost migrant shelter funds. Meanwhile, companies are tapping into AI for personalized pricing, sparking privacy worries, and psilocybin emerges as a promising agent for extending mice lifespans.